Drug Shortage Report for AZITHROMYCIN FOR INJECTION, USP

Last updated on 2017-11-24 History
Report ID 14721
Drug Identification Number 02334844
Brand name AZITHROMYCIN FOR INJECTION, USP
Common or Proper name AZITHROMYCIN
Company Name HOSPIRA HEALTHCARE ULC
Active Ingredient(s) AZITHROMYCIN
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 10x500mg
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2018-03-06
Actual start date
Estimated end date Unknown
Actual end date 2017-09-30
Shortage status Avoided shortage
Updated date 2017-11-24
Company comments Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / Service à la clientele 1-866-488-6088 option 3

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2017-11-24 French Compare
v4 2017-11-24 English Compare
v3 2017-11-24 English Compare
v2 2017-07-05 French Compare
v1 2017-07-05 English Compare